Skip to main content

"We've detected that you're visiting from {0}. Would you like to switch languages for tailored content?"

Reduce the risk of infection for all vascular access devices

Every IV access is at potential risk of infection, dislodgement, skin damage and other complications. These can lead to patient discomfort and pain, longer hospital stays, additional therapy and surgical procedures — or even have consequences on mortality.

Prevent bloodstream infections with solutions designed to secure and protect every IV catheter — from insertion to removal.

Img IV Care_web_antimicrobial-hero_1200x350.jpg

Explore our range of solutions to lower your patients’ risk of BSI

From transparent film dressings and strong adhesive fixation dressings to antimicrobial dressings and disinfection caps, our broad portfolio makes it easy for you to select and use the right products for every patient.

Evidence and guidance

Discover the latest evidence and expert guidance to reduce catheter-related bloodstream infections. Empower your practice with insights and best practices to improve patient outcomes.

Contact a Solventum representative

We're here to help! Our team of representatives can provide you with information and resources to help you. Submit the form below to speak with a Solventum representative to learn more about your options.

Looking for customer support? Visit the customer support page.

Fields marked with an * are required.

Please enter your professional email address

There was an error processing your request. Please try again later.

There was an error processing your request. Please try again later.

References:

  1. Maki D, Mermel L. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Bennett & Brachman’s Hospital Infections. 4th ed. Philadelphia: Lippincott-Raven; 1998:689-724.
  2. Centers for Disease Control and Prevention. Vital Signs: Making health care safer: Reducing bloodstream infections. Published March, 2011. Accessed November 26, 2024. https://www.cdc.gov/vitalsigns/pdf/2011-03-vitalsigns.pdf
  3. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41(11):1591-1598. doi:10.1086/497833
  4. Zimlichman E, Henderson D, Tamir O, et al. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern Med. 2013;173(22):2039-2046. doi:10.1001/jamainternmed.2013.9763
  5. Scheithauer S, Lewalter K, Schröder J, et al. Reduction of central venous line-associated bloodstream infection rates by using a chlorhexidine-containing dressing. Infection. 2014;42(1):155-159. doi:10.1007/s15010-013-0519-7
  6. Timsit JF, Mimoz O, Mourvillier B, et al. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults. Am J Respir Crit Care Med. 2012;186(12):1272-1278. doi:10.1164/rccm.201206-1038OC
  7. Loveday HP, Wilson JA, Prieto J, Wilcox MH. epic3: revised recommendation for intravenous catheter and catheter site care. J Hosp Infect. 2016;92(4):346-348. doi:10.1016/j.jhin.2015.11.011
  8. National Institute for Health and Care Excellence. Medical technologies guidance [MTG25]. Tegaderm CHG IV securement dressing for central venous and arterial catheter insertion sites. Published September 2019. Accessed November 25, 2024. www.nice.org.uk/guidance/mtg25